Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.06 CHF | +0.40% | -2.49% | -3.98% |
Apr. 26 | Baloise shareholders vote in favor of scrapping 2% voting ceiling | RE |
Apr. 24 | Roche’s Downbeat Q1 Sales Drag Swiss Market Index to Red | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company appears to be poorly valued given its net asset value.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The firm trades with high earnings multiples: 33.47 times its 2024 earnings per share.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.98% | 87.91B | C+ | ||
-6.03% | 113B | A- | ||
+20.42% | 63.85B | C | ||
+5.29% | 61.9B | - | B+ | |
+10.12% | 42.86B | C+ | ||
+7.95% | 40.84B | A- | ||
+18.92% | 34.58B | A- | ||
+5.88% | 25.46B | B | ||
-5.25% | 22.13B | A- | ||
+0.57% | 18.61B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UBSG Stock
- Ratings UBS Group AG